Balimbingan, Juhari S.

HRN: 28-64-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
CEFTRIAXONE 1G (VIAL)
03/06/2026
03/13/2026
PO
2g
Od
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: